HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

07.08.2025 - 18:05:10

65 Equity Partners HAS Healthcare Advanced Synthesis United Kingdom United States of America Austria Belgium France Germany Italy Netherlands Spain Switzerland

This major acquisition in Ticino will allow the two companies to combine their forces of production, chemical and biological expertise, know-how and technological capabilities, creating new opportunities of growth and driving business development to establish itself as an international quality leader in the CDMO (Contract Development and Manufacturing Organization) industry.65 Equity Partners backs merger, partnering with these family businesses and entrepreneurs in this acquisition and merger process to drive long-term company growth and innovation. and follow us on Linkedin

About 65 Equity Partners

65 Equity Partners is a global investment firm that partners with founders, families, and entrepreneurs across Europe, North America, and Asia to build sustainable, long-term value. We invest in leading businesses across the healthcare, industrial, business services, technology, and consumer sectors.

Backed by Temasek as an independently managed investment platform with US$3.3 billion in funds under management, we provide equity and structured capital solutions to established companies with regional or global growth ambitions. With offices in London, Singapore, New York, and San Francisco, we leverage our local roots, international network and the deep expertise of our broader ecosystem.

For more information, visit our website at https://www.65equitypartners.com/ and follow us on LinkedIn.

For further information, contact:

HAS Healthcare Advanced Synthesis SA
Biasca, Switzerland
Press Office:
Giacomo Braglia
Tel: +41 (0) 91 873 94 00
Email: mediarelations@hashealthcare.com

65 Equity Partners
Greenbrook
Peter Hewer, Theo Bryan, Long Tran
Email: 65EP@greenbrookadvisory.com

Logo - https://mma.prnewswire.com/media/2652221/65_Equity_Partners_Logo.jpg
Logo - https://mma.prnewswire.com/media/2652224/HAS_Logo.jpg
Logo - https://mma.prnewswire.com/media/2652222/Cerbios_Logo.jpg